380 results on '"Kwon, Ghee Young"'
Search Results
2. Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer
3. New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation
4. Effects of Treating Subclinical Rejection 2 Weeks After Kidney Transplantation, as Determined by Analyzing 1-Year Histologic Outcomes
5. The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer
6. Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomas
7. Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis
8. Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers
9. Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
10. Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies
11. Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study
12. Analysis of chromosome 12p over-representation and clinicopathological features in mediastinal teratomas
13. Intraoperative Microvascular Thrombosis Secondary to Henoch-Schönlein Purpura of Hidden Onset
14. Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer
15. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization
16. DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7
17. Supplementary Figure 3 from A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations
18. Supplementary Figure 2 from A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations
19. Supplementary Figure 1 from A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations
20. Supplementary Figure Legends from A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations
21. Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
22. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs
23. Microsteatosis may not interact with macrosteatosis in living donor liver transplantation
24. Preclinical xeno-kidney transplantation of pig to cynomolgus non-human primate: 2 years of experience
25. Fat and protein modification affects the repair process in ischemic acute kidney injury
26. Delayed treatment with poly (ADP-Ribose) polymerase inhibitor during healing phase of ischemic acute kidney injury
27. Patterns of Extrathoracic Metastasis in Lung Cancer Patients
28. Neoadjuvant Nivolumab plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
29. Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation
30. Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems
31. Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
32. Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
33. Effects of Treating Subclinical Rejection 2 Weeks after Kidney Transplantation, as Determined by Analyzing 1-Year Histologic Outcomes
34. Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy Followed by Radical Cystectomy: A Single-Center Retrospective Study
35. CD13 is a marker for onychofibroblasts within nail matrix onychodermis: Comparison of its expression patterns in the nail unit and in the hair follicle
36. A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma
37. Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma
38. Repair phase modeling of ischemic acute kidney injury: recovery vs. transition to chronic kidney disease
39. A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
40. Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma
41. Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
42. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate
43. Scattered atypical melanocytes with hyperchromatic nuclei in the nail matrix: diagnostic clue for early subungual melanoma in situ
44. Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features
45. Leiomyoma of the Urinary Bladder: A Series of Nine Cases and Review of the Literature
46. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract
47. Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases
48. Dietary Modification Alters the Intrarenal Immunologic Micromilieu and Susceptibility to Ischemic Acute Kidney Injury
49. Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features
50. Adrenal tumors with late enhancement on CT and MRI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.